MarketBeat Instant News Alerts 2 hours agoJPMorgan Chase & Co. Increases Advanced Micro Devices (NASDAQ:AMD) Price Target to $550.00MarketBeatJPMorgan Chase & Co. boosted their price objective on Advanced Micro Devices from $385.00 to $550.00 and gave the stock a "neutral" rating in a research note on Wednesday.NASDAQ:AMDRead JPMorgan Chase & Co. Increases Advanced Micro Devices (NASDAQ:AMD) Price Target to $550.002 hours agoHC Wainwright Lowers Blink Charging (NASDAQ:BLNK) Price Target to $2.50MarketBeatHC Wainwright decreased their price objective on shares of Blink Charging to $2.50 and set a "buy" rating on the stock in a report on Friday.NASDAQ:BLNKRead HC Wainwright Lowers Blink Charging (NASDAQ:BLNK) Price Target to $2.502 hours agoBTIG Research Forecasts Strong Price Appreciation for Caris Life Sciences (NASDAQ:CAI) StockMarketBeatBTIG Research increased their target price on Caris Life Sciences from $32.00 to $33.00 and gave the company a "buy" rating in a research report on Thursday.NASDAQ:CAIRead BTIG Research Forecasts Strong Price Appreciation for Caris Life Sciences (NASDAQ:CAI) Stock2 hours agoNeedham & Company LLC Lowers Celsius (NASDAQ:CELH) Price Target to $35.00MarketBeatNeedham & Company LLC decreased their target price on Celsius from $55.00 to $35.00 and set a "buy" rating on the stock in a research report on Thursday.NASDAQ:CELHRead Needham & Company LLC Lowers Celsius (NASDAQ:CELH) Price Target to $35.002 hours agoChime Financial (NASDAQ:CHYM) Stock Price Expected to Rise, Barclays Analyst SaysMarketBeatBarclays increased their target price on shares of Chime Financial from $26.00 to $33.00 and gave the stock an "overweight" rating in a research note on Friday.NASDAQ:CHYMRead Chime Financial (NASDAQ:CHYM) Stock Price Expected to Rise, Barclays Analyst Says2 hours agoBarclays Forecasts Strong Price Appreciation for Celldex Therapeutics (NASDAQ:CLDX) StockMarketBeatBarclays raised their price objective on shares of Celldex Therapeutics from $48.00 to $53.00 and gave the stock an "overweight" rating in a research report on Friday.NASDAQ:CLDXRead Barclays Forecasts Strong Price Appreciation for Celldex Therapeutics (NASDAQ:CLDX) Stock Trending News1Archer Aviation (ACHR) Projected to Announce Quarterly Earnings on Monday2Celsius Q2 Earnings Call Highlights3Rocket Lab (RKLB) to Post Quarterly Earnings on Monday4Northland Securities Predicts BigBear.ai Q1 Earnings5Plug Power (PLUG) Expected to Release Quarterly Earnings on Monday6Nokia (NYSE:NOK) Shares Up 2.3% - Here's Why7Advanced Micro Devices Q2 Earnings Call Highlights8Ondas (NASDAQ:ONDS) Shares Up 11.7% - Should You Buy? All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoCommerce.com's (CMRC) "Hold" Rating Reaffirmed at Canaccord Genuity GroupMarketBeatNASDAQ:CMRCRead Commerce.com's (CMRC) "Hold" Rating Reaffirmed at Canaccord Genuity Group2 hours agoNeedham & Company LLC Issues Positive Forecast for CryoPort (NASDAQ:CYRX) Stock PriceMarketBeatNASDAQ:CYRXRead Needham & Company LLC Issues Positive Forecast for CryoPort (NASDAQ:CYRX) Stock Price2 hours agoBTIG Research Forecasts Strong Price Appreciation for JFrog (NASDAQ:FROG) StockMarketBeatNASDAQ:FROGRead BTIG Research Forecasts Strong Price Appreciation for JFrog (NASDAQ:FROG) Stock2 hours agoICU Medical (NASDAQ:ICUI) Price Target Raised to $187.00 at Needham & Company LLCMarketBeatNASDAQ:ICUIRead ICU Medical (NASDAQ:ICUI) Price Target Raised to $187.00 at Needham & Company LLC2 hours agoBTIG Research Increases LifeStance Health Group (NASDAQ:LFST) Price Target to $16.00MarketBeatNASDAQ:LFSTRead BTIG Research Increases LifeStance Health Group (NASDAQ:LFST) Price Target to $16.002 hours agoPapa John's International's (PZZA) "Equal Weight" Rating Reaffirmed at StephensMarketBeatNASDAQ:PZZARead Papa John's International's (PZZA) "Equal Weight" Rating Reaffirmed at Stephens2 hours agoNeedham & Company LLC Cuts Red Cat (NASDAQ:RCAT) Price Target to $15.00MarketBeatNASDAQ:RCATRead Needham & Company LLC Cuts Red Cat (NASDAQ:RCAT) Price Target to $15.002 hours agoHC Wainwright Reaffirms Buy Rating for Red Cat (NASDAQ:RCAT)MarketBeatNASDAQ:RCATRead HC Wainwright Reaffirms Buy Rating for Red Cat (NASDAQ:RCAT)2 hours agoJonesTrading Has Lowered Expectations for Real Brokerage (NASDAQ:REAX) Stock PriceMarketBeatNASDAQ:REAXRead JonesTrading Has Lowered Expectations for Real Brokerage (NASDAQ:REAX) Stock Price2 hours agoBarclays Reiterates "Equal Weight" Rating for REGENXBIO (NASDAQ:RGNX)MarketBeatNASDAQ:RGNXRead Barclays Reiterates "Equal Weight" Rating for REGENXBIO (NASDAQ:RGNX)2 hours agoCantor Fitzgerald Has Lowered Expectations for SharonAI Holdings, Inc. Class A Common Stock (NASDAQ:SHAZ) Stock PriceMarketBeatNASDAQ:SHAZRead Cantor Fitzgerald Has Lowered Expectations for SharonAI Holdings, Inc. Class A Common Stock (NASDAQ:SHAZ) Stock Price2 hours agoCantor Fitzgerald Forecasts Strong Price Appreciation for Trevi Therapeutics (NASDAQ:TRVI) StockMarketBeatNASDAQ:TRVIRead Cantor Fitzgerald Forecasts Strong Price Appreciation for Trevi Therapeutics (NASDAQ:TRVI) Stock2 hours agoBank of America Initiates Coverage on Tower Semiconductor (NASDAQ:TSEM)MarketBeatNASDAQ:TSEMRead Bank of America Initiates Coverage on Tower Semiconductor (NASDAQ:TSEM)2 hours agoTexas Roadhouse (NASDAQ:TXRH) Price Target Raised to $230.00 at TD CowenMarketBeatNASDAQ:TXRHRead Texas Roadhouse (NASDAQ:TXRH) Price Target Raised to $230.00 at TD Cowen2 hours agoTexas Roadhouse (NASDAQ:TXRH) Price Target Raised to $205.00 at StephensMarketBeatNASDAQ:TXRHRead Texas Roadhouse (NASDAQ:TXRH) Price Target Raised to $205.00 at Stephens2 hours agoTexas Roadhouse (NASDAQ:TXRH) Price Target Raised to $220.00MarketBeatNASDAQ:TXRHRead Texas Roadhouse (NASDAQ:TXRH) Price Target Raised to $220.002 hours agoBarclays Issues Positive Forecast for American International Group (NYSE:AIG) Stock PriceMarketBeatNYSE:AIGRead Barclays Issues Positive Forecast for American International Group (NYSE:AIG) Stock Price2 hours agoBTIG Research Raises ATI (NYSE:ATI) Price Target to $270.00MarketBeatNYSE:ATIRead BTIG Research Raises ATI (NYSE:ATI) Price Target to $270.002 hours agoEtsy (NYSE:ETSY) Upgraded at JPMorgan Chase & Co.MarketBeatNYSE:ETSYRead Etsy (NYSE:ETSY) Upgraded at JPMorgan Chase & Co.2 hours agoEtsy (NYSE:ETSY) Price Target Raised to $100.00 at Needham & Company LLCMarketBeatNYSE:ETSYRead Etsy (NYSE:ETSY) Price Target Raised to $100.00 at Needham & Company LLC2 hours agoBTIG Research Increases FIGS (NYSE:FIGS) Price Target to $22.00MarketBeatNYSE:FIGSRead BTIG Research Increases FIGS (NYSE:FIGS) Price Target to $22.002 hours agoGarmin (NYSE:GRMN) Price Target Raised to $370.00MarketBeatNYSE:GRMNRead Garmin (NYSE:GRMN) Price Target Raised to $370.002 hours agoKarman (NYSE:KRMN) Price Target Cut to $80.00 by Analysts at Needham & Company LLCMarketBeatNYSE:KRMNRead Karman (NYSE:KRMN) Price Target Cut to $80.00 by Analysts at Needham & Company LLC2 hours agoCloudflare (NYSE:NET) Price Target Raised to $382.00MarketBeatNYSE:NETRead Cloudflare (NYSE:NET) Price Target Raised to $382.00 Featured Articles and OffersSpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have ControlBy Jeffrey Neal Johnson | August 3, 2026Trump Takes Emergency Action - Plus Elon Musk's New VentureFrom Altimetry (Ad)3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income StoryBy Nathan Reiff | August 2, 2026System Upgrade: First Internet Bancorp Options SurgeBy Jeffrey Neal Johnson | August 4, 2026Tilray Brands (NASDAQ:TLRY) Rating Increased to Strong-Buy at TD SecuritiesBy MarketBeat | August 1, 2026A letter from Shannon StansberryFrom Porter & Company (Ad)AMD’s Post-Earnings Drop May Be the Opportunity Investors WantedBy Thomas Hughes | August 5, 2026AbbVie Quietly Solved Its Biggest Problem—Now What?By Thomas Hughes | August 2, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 544 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
